Clinical Trials Key to Winning Battle vs. HIV/AIDS
Much of the progress in the fight against HIV/AIDS has come through new therapies tested in clinical trials. To maintain this progress, continuing participation in trials will be vital . . .
Friday, June 6, 2003
Listen to Medminute audio
Durham, N.C. -- Medical science is making significant
strides in the battle against HIV/AIDS. However, there is a
continuing need for HIV/AIDS patients to take part in trials of new
drugs and strategies. Dr. John Bartlett, principal investigator in
the Adult AIDS Clinical Trials Unit at Duke University Medical
Center, says clinical trials serve patients by providing access to
the latest medications, plus careful monitoring, at little or no
cost. Trials also provide patients with other important
resources.
"Our research nurses are very attentive and provide both physical and emotional support to research participants. The study physicians may also play an important role in adding to expert care."
Patients whose own treatments are working well may not recognize the need to participate in trials, but Bartlett says it's the best way to push ahead in the fight against the disease.
"We should not feel complacent about HIV-AIDS. There are still substantial challenges that we face."
